As these results highlight the important influence of ER status in HER2-positive breast cancer, we evaluated all further analyses with and without adjusting for ER status as well as per HER2-positive/ER-positive and HER2-positive/ER-negative subgroups. The gene discussed is ESR1; the disease is breast cancer.